Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 28, 2014
Jun. 29, 2013
Cash flows from operating activities:    
Net income $ 23,571 $ 21,365
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,212 3,565
(Gain)Loss on disposal of assets 134 15
Gain on investment in business 0 (528)
Provision for deferred income taxes 50 (14)
Allowance for doubtful accounts 0 (29)
Stock-based compensation expense 1,853 1,416
(Increase) decrease in, net of assets acquired:    
Accounts receivable (5,682) (6,740)
Inventories (856) 186
Income taxes receivable 954 728
Other current assets (1,601) (677)
Other assets (99) 258
Increase (decrease) in, net of liabilities assumed:    
Accounts payable 1,346 864
Accrued expenses and other liabilities 2,752 1,617
Income taxes payable 21 1,430
Other noncurrent liabilities 17 (1)
Net cash provided by operating activities 26,672 23,455
Payments to Acquire Businesses, Net of Cash Acquired 0 923
Cash flows from investing activities:    
Capital expenditures (5,057) (9,518)
Purchases of short-term investments (18,990) (11,888)
Proceeds from sale of short-term investments 19,149 11,744
Net cash used in investing activities (4,898) (10,585)
Cash flows from financing activities:    
Proceeds from stock issued 409 466
Dividends to shareholders (7,129) (4,710)
Change in restricted cash (20) 21
Net cash used in financing activities (6,740) (4,223)
Effect of exchange rate changes on cash and cash equivalents 2,193 (1,439)
Net increase (decrease) in cash and cash equivalents 17,227 7,208
Cash and cash equivalents, beginning of period 54,912 34,478
Cash and cash equivalents, end of period 72,139 41,686
Cash paid:    
Income taxes 10,775 8,161
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities 3,226 3,486
Common stock issued for deferred director’s compensation through other noncurrent liabilities $ 0 $ 294